01.02.2021 • News

Brenntag Buys UK’s ICL Packed

Brenntag has strengthened its water treatment business in the UK with the acquisition of ICL Packed, its second purchase this year so far. Financial terms of the deal, which was signed and closed on the same day, were not disclosed.

“We see a very positive outlook for the water treatment business in the UK over the years to come due to population growth and the increased pressure on environmental quality,” said Steven Terwindt, member of Brenntag Group’s management board and chief operating officer of Brenntag Essentials.The acquisition will not only strengthen our position in water treatment, but also in core market sectors in the region.”

The transaction also includes a supply agreement between Brenntag and ICL, which is a large manufacturer of caustic soda, hydrochloric acid, aluminum coagulants and sodium hypochlorite. The acquired business is expected to generate sales of approximately £11 million in the 2020 fiscal year 2020.

Just a few days ago, Brenntag also announced the purchase of a 67% shareholding in Chinese specialty ingredients distributor Zhongbai Xingye. The Germany-based multinational distribution group intends to buy the remaining 33% by the end of 2024.

Author: Ellaine Burridge, Freelance Journalist

Brenntag has strengthened its water treatment business in the UK with the...
Brenntag has strengthened its water treatment business in the UK with the acquisition of ICL Packed, its second purchase this year so far. The acquired business is expected to generate sales of approximately £11 million in the 2020 fiscal year 2020. (c) Aleksandr Slobodianyk

Company

Logo:

Brenntag SE

Messeallee 11
45131 Essen
Germany

Company contact







From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read